Healthcare law business Frier Levitt has analyzed FDA enforcement actions towards “research only” peptide suppliers. Their conclusion: the FDA considers an item’s classification dependant on its supposed use, not its disclaimers. When Internet websites contain dosage guides, reconstitution Recommendations, or backlink to community forums spea… Read More